Journal of Innovation in Pharmaceutical Sciences
  • Year: 2018
  • Volume: 2
  • Issue: 1

A Review on Monoclonal Antibodies

  • Author:
  • P. Suchitra Devi, Abbaraju Krishna, Sailaja
  • Total Page Count: 6
  • Page Number: 27 to 32

Department of pharmaceutics, RBVRR women's college of pharmacy, Barkatpura, Hyderabad, India-500027

*Correspondence to: P. Suchitra devi, Research Scholar, Department of pharmaceutics, 3-4-343, RBVRR women's college of pharmacy, Barkatpura, Hyderabad-500027, India. E-mail address: shailaja1234@rediffmail.com

Online published on 27 September, 2019.

Abstract

Monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells or proteins. MAB's have increased demand in the diagnostic and therapeutic applications. Some antibodies with few adverse effects are used for treatment of cancer and infectious disease. Large amount of research and development currently being undergone to create monoclonal for numerous serious diseases also.monoclonal antibody technology was quickly adopted by scientists in both industry and academia led to unlimited usefulness of monoclonal antibodies. This review explains about the monoclonal antibodies importance, types and their applications.

Keywords

Antibodies, Antigen, immunity, B-Lymphocytes, Hybridoma technology